The weight-loss drugs being tested in 2025: will they beat Ozempic?The weight-loss drugs being tested in 2025: will they beat Ozempic?
An ongoing trial of Zepbound (tirzepatide) is testing effects on heart disease in people with obesity and diabetes.Credit: Shelby Knowles/Bloomberg via Getty As appetite for blockbuster weight-loss drugs grows worldwide,